Jun Lu1, Elizabeth L Frank. 1. ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA. jun.lu@aruplab.com
Abstract
BACKGROUND: Thiamine (vitamin B(1)) deficiency is associated with severe diseases such as beriberi and Wernicke encephalopathy. Although most Americans have sufficient dietary intake, thiamine deficiency is observed in the alcohol-dependent and elderly populations. Measurement of thiamine concentration in whole blood provides an assessment of vitamin B(1) status in at-risk individuals. METHOD: We used TCA to precipitate proteins in whole blood. Thiamine and its phosphate esters were derivatized using potassium ferricyanide to thiochromes, which were separated by gradient elution on a reversed-phase HPLC column and detected by fluorescence. The method was validated for linearity, limit of quantification, imprecision, accuracy, and interference. Results obtained with this method were compared with those produced by the method currently used in our clinical laboratory. Reference values of thiamine and its phosphate esters were determined in samples obtained from self-reported healthy adults who were not taking vitamin supplements. To shorten analysis time, our method used whole blood rather than washed erythrocytes, did not require lengthy enzymatic dephosphorylation, and had a simple mobile phase. RESULTS: The method was linear to 4000 nmol/L. The lower limit of quantification was 3 nmol/L. The within-run CV was <3.5% and total CV was <9.4%. This method correlated with our current method (r = 0.97). Approximately 90% of the total thiamine content in whole blood was present as thiamine diphosphate (TDP). The means (ranges) for an apparently healthy population were 114 (70-179) nmol/L for TDP and 125 (75-194) nmol/L for total thiamine. Results for separation and measurement of free thiamine and thiamine phosphate esters in whole blood were obtained within 5.5 min. CONCLUSION: We developed an HPLC method that allows separation and measurement of free thiamine and thiamine phosphate esters in whole blood and provides more rapid results than other methods.
BACKGROUND:Thiamine (vitamin B(1)) deficiency is associated with severe diseases such as beriberi and Wernicke encephalopathy. Although most Americans have sufficient dietary intake, thiamine deficiency is observed in the alcohol-dependent and elderly populations. Measurement of thiamine concentration in whole blood provides an assessment of vitamin B(1) status in at-risk individuals. METHOD: We used TCA to precipitate proteins in whole blood. Thiamine and its phosphate esters were derivatized using potassium ferricyanide to thiochromes, which were separated by gradient elution on a reversed-phase HPLC column and detected by fluorescence. The method was validated for linearity, limit of quantification, imprecision, accuracy, and interference. Results obtained with this method were compared with those produced by the method currently used in our clinical laboratory. Reference values of thiamine and its phosphate esters were determined in samples obtained from self-reported healthy adults who were not taking vitamin supplements. To shorten analysis time, our method used whole blood rather than washed erythrocytes, did not require lengthy enzymatic dephosphorylation, and had a simple mobile phase. RESULTS: The method was linear to 4000 nmol/L. The lower limit of quantification was 3 nmol/L. The within-run CV was <3.5% and total CV was <9.4%. This method correlated with our current method (r = 0.97). Approximately 90% of the total thiamine content in whole blood was present as thiamine diphosphate (TDP). The means (ranges) for an apparently healthy population were 114 (70-179) nmol/L for TDP and 125 (75-194) nmol/L for total thiamine. Results for separation and measurement of free thiamine and thiamine phosphate esters in whole blood were obtained within 5.5 min. CONCLUSION: We developed an HPLC method that allows separation and measurement of free thiamine and thiamine phosphate esters in whole blood and provides more rapid results than other methods.
Authors: Mingguang Li; Brian J Petteys; Julie M McClure; Veena Valsakumar; Stefan Bekiranov; Elizabeth L Frank; Jeffrey S Smith Journal: Mol Cell Biol Date: 2010-05-03 Impact factor: 4.272
Authors: Johannes A Mayr; Peter Freisinger; Kurt Schlachter; Boris Rolinski; Franz A Zimmermann; Thomas Scheffner; Tobias B Haack; Johannes Koch; Uwe Ahting; Holger Prokisch; Wolfgang Sperl Journal: Am J Hum Genet Date: 2011-12-09 Impact factor: 11.025
Authors: Jelisa Gallant; Kathleen Chan; Tim J Green; Frank T Wieringa; Shalem Leemaqz; Rem Ngik; Jeffrey R Measelle; Dare A Baldwin; Mam Borath; Prak Sophonneary; Lisa N Yelland; Daniela Hampel; Setareh Shahab-Ferdows; Lindsay H Allen; Kerry S Jones; Albert Koulman; Damon A Parkington; Sarah R Meadows; Hou Kroeun; Kyly C Whitfield Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045
Authors: Dèlia Yubero; Raquel Montero; Mar O'Callaghan; Mercè Pineda; Silvia Meavilla; Veronica Delgadillo; Cristina Sierra; Laura Altimira; Plácido Navas; Simon Pope; Marcus Oppenheim; Viruna Neergheen; Arunabha Ghosh; Phillipa Mills; Peter Clayton; Emma Footitt; Maureen Cleary; Iain Hargreaves; Simon A Jones; Simon Heales; Rafael Artuch Journal: JIMD Rep Date: 2015-07-24